Sharfstein Heads FDA Transparency Task Force

FDA's formation of an internal "Transparency Task Force" is a savvy approach that allows agency leaders to begin making good now on their pledges to enhance openness while giving them six months to decide whether to release any specific new information

More from Archive

More from Pink Sheet